Despite Questionable Data, Drug for ALS Wins FDA Approval – NBC 5 Dallas-Fort Worth
A much-debated drug for Lou Gehrig’s disease won U.S. approval Thursday, a long-sought victory for patients that is likely to renew questions about the...
Stay updated with breaking news from Billy Dunn. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
A much-debated drug for Lou Gehrig’s disease won U.S. approval Thursday, a long-sought victory for patients that is likely to renew questions about the...
A much-debated drug for Lou Gehrig’s disease won U.S. approval Thursday. Read more on Boston.com.
Amylyx Pharmaceuticals Inc said on Thursday the U.S. Food and Drug Administration approved its drug for slowing progression of ALS, or amyotrophic lateral sclerosis, and potentially delaying death,... | September 30, 2022
Agency's decision comes after questions about the drug's effectiveness
Patients with the deadly neurological disease have rallied behind the drug from Amylyx Pharma and are lobbying the FDA for approval.